
Sign up to save your podcasts
Or


If you’ve ever heard that menopausal hormone therapy can increase the risk of breast cancer, this new health report may surprise you.
In this bonus episode, women’s health and menopause management expert Dr. Mindy Goldman sheds light on the complex world of Menopause Hormone Therapy. We explore pivotal insights from the Ester Trial, revealing potentially safer transdermal estrogen. We talk about a fascinating Today article that uncovers the impact of statistical manipulation on reported studies, especially concerning the relationship between breast cancer and hormone therapy.
Dr. Mindy Goldman shares her expert opinion on how estrogen alone might be safer than we thought, and why synthetic progesterone requires a closer look. We also discuss the controversial use of testosterone in women, the challenges with federal laws, and FDA-approved options for improving libido.
Dr. Goldman is a Clinical Professor in the Department of OB/GYN at UCSF and the Director of the Gynecology Center for Cancer Survivors and At-Risk Women. In addition to her role as Midi’s Chief Clinical Officer, she’s a nationally recognized expert in the management of women’s health issues, including menopause, for women with cancer or at high risk. She helped author guidelines for the American College of Obstetrics and Gynecology (ACOG) and has won several notable awards.
Discussed in this episode:
Related to this episode:
If you're passionate about advancing women's health, there are many ways you can support the Fempower Health Podcast. Here's how:
Together, let's build a stronger community dedicated to women's health. Your support is crucial in this journey!
**The information shared by Fempower Health is not medical advice but for informational purposes to enable you to have more effective conversations with your doctor. Always talk to your doctor before making health-related decisions. Additionally, the views expressed by the Fempower Health podcast guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.**
By Georgie Kovacs4.5
22 ratings
If you’ve ever heard that menopausal hormone therapy can increase the risk of breast cancer, this new health report may surprise you.
In this bonus episode, women’s health and menopause management expert Dr. Mindy Goldman sheds light on the complex world of Menopause Hormone Therapy. We explore pivotal insights from the Ester Trial, revealing potentially safer transdermal estrogen. We talk about a fascinating Today article that uncovers the impact of statistical manipulation on reported studies, especially concerning the relationship between breast cancer and hormone therapy.
Dr. Mindy Goldman shares her expert opinion on how estrogen alone might be safer than we thought, and why synthetic progesterone requires a closer look. We also discuss the controversial use of testosterone in women, the challenges with federal laws, and FDA-approved options for improving libido.
Dr. Goldman is a Clinical Professor in the Department of OB/GYN at UCSF and the Director of the Gynecology Center for Cancer Survivors and At-Risk Women. In addition to her role as Midi’s Chief Clinical Officer, she’s a nationally recognized expert in the management of women’s health issues, including menopause, for women with cancer or at high risk. She helped author guidelines for the American College of Obstetrics and Gynecology (ACOG) and has won several notable awards.
Discussed in this episode:
Related to this episode:
If you're passionate about advancing women's health, there are many ways you can support the Fempower Health Podcast. Here's how:
Together, let's build a stronger community dedicated to women's health. Your support is crucial in this journey!
**The information shared by Fempower Health is not medical advice but for informational purposes to enable you to have more effective conversations with your doctor. Always talk to your doctor before making health-related decisions. Additionally, the views expressed by the Fempower Health podcast guests are their own and their appearance on the program does not imply an endorsement of them or any entity they represent.**

32,120 Listeners

112,394 Listeners

43 Listeners

627 Listeners

167 Listeners

20,420 Listeners

199 Listeners

25 Listeners

0 Listeners